GASTRIC OR GASTRO ESOPHAGEAL JUNCTION ADENOCARCINOMA

Clinical trials for GASTRIC OR GASTRO ESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new GASTRIC OR GASTRO ESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for GASTRIC OR GASTRO ESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for tough stomach cancers: major trial tests Next-Generation drug

Disease control Recruiting now

This study is testing a new drug called BL-M07D1 for people with advanced HER2-positive stomach or gastroesophageal cancer that has worsened after their first treatment. It will compare the new drug against standard chemotherapy to see which is better at helping patients live lon…

Matched conditions: GASTRIC OR GASTRO ESOPHAGEAL JUNCTION ADENOCARCINOMA

Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Apr 04, 2026 00:50 UTC

GASTRIC OR GASTRO ESOPHAGEAL JUNCTION ADENOCARCINOMA

Get alerted when new GASTRIC OR GASTRO ESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

New hope for tough stomach cancers: major trial tests Next-Generation drug